medigraphic.com

2000, Número 5

<< Anterior Siguiente >>

Arch Cardiol Mex 2000; 70 (5)


Valoración de la función ventricular mediante cardiología nuclear. Parte II. Aplicaciones clínicas

Márquez MF, Alexánderson E, Roldán FJ

Idioma: Español
Referencias bibliográficas: 84
Paginas: 499-512
Archivo PDF: 132.96 Kb.


FRAGMENTO

I. EVALUACIÓN DE LA FUNCIÓN VENTRICULAR IZQUIERDA

I.A. EVALUACIÓN DE LA FUNCIÓN SISTÓLICA

Resulta muy importante para el médico que se enfrenta al reto de manejar enfermos con alguna cardiopatía el conocer la repercusión funcional de la misma. Muchas veces de ello depende el plan terapéutico, incluyendo en muchas ocasiones, la toma de decisiones quirúrgicas.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Martínez-Ríos MA: Valoración hemodinámica y angiográfica de la función ventricular. Arch Inst Cardiol Méx 1973; 43(6): 803-805.

  2. Dries DL, Rosenberg YD, Waclawiw MA, Domanski MJ: Ejection fraction and risk of thromboembolism events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trials. Circulation 1997; 29(5): 1074-1080.

  3. Barretto AC, Pileggi F: Disfunçáo ventricular. A importância do diagnóstico precoce. Arq Bras Cardiol 1996; 67(5): 313-315.

  4. González-Hermosillo JA: Risk stratification for malignant arrhythmias after myocardial infarction. A reappraisal in the era of thrombolysis. Arch Inst Cardiol Méx 1997; 67(3): 183-185.

  5. Rumberger JA, Behrenbeck T, Bell MR, Breen JF, Johnston DL, Holmes DR, et al: for the Cardiovascular Imaging Working Group: Determination of ventricular ejection fraction: A comparison of available imaging methods. Mayo Clin Proc 1997; 72: 860-870.

  6. Lethimonnier F, Furber A, Balzer P, Morel O, Rouleau F, Delepine S, et al: Global left ventricular cardiac function: comparison between magnetic resonance imaging, radionuclide angiography, and contrast angiography. Invest Radiol 1999; 34(3): 199-203.

  7. Mustonen JN, Uusitupa MIJ, Laakso M, Vanninen E, Lansimies E, Kuikka JT, et al: Left ventricular systolic function in middle-aged patients with diabetes mellitus. Am J Cardiol 1994; 73(16): 1202-1208.

  8. Esquerre JP, Coca FJ, Gantet P, Ouhayoun E: Feasibility of first-pass radionuclide angiocardiography with a 10-mCi technetium bolus using a single-crystal digital gamma camera: implications for technetium-sestamibi single-day protocols. Eur J Nuci Med 1995; 22(6): 521-527.

  9. Urena PE, Lamas GA, Mitchell G, Flaker GC, Smith SC Jr, Wackers FJ, et al: Ejection fraction by radionuclide ventriculography and contrast left ventriculogram. A tale of two techniques. SAVE Investigators. Survival and Ventricular Enlargement. J Am Coll Cardiol 1999; 33(1): 180-185.

  10. Gioia G, Bagheri B, Schwartzman DS, Callans D, Marchilinski F, Gottlieb C, et al: The relationship of left ventricular diastolic volume to outcome in patients with life threatening arrhythmias. J Nucl Med 1996; 37(5, suppl.): 149P.

  11. Atherton JJ, Moore ThD, Lele SS, Thomson HL, Galbraith AJ, Belenkie I, et al: Diastolic ventricular interaction in chronic heart failure. Lancet 1997; 349(9067): 1720-1724.

  12. Guadalajara JF, Galván O, Huerta D: Evaluación de la cardiopatía isquémica mediante ecocardiografía dinámica. Arch Inst Cardiol Méx 1997; 67(3): 231-241.

  13. Lupi E, Montenegro A, Ramírez JC, González H, Martínez C, Juárez U: Infarto experimental del ventrículo derecho. Su historia natural. Arch Inst Cardiol Méx 1997; 67(2): 91-100.

  14. Mena I: Evaluación de la función ventricular en la insuficiencia coronaria. En: Cuarón A. “Cardiología Nuclear. Aplicaciones Clínicas”. 1ª ed. México, D.F. Compañía Editorial Continental 1987: 356-358.

  15. Johnson R, Rubin L: Noninvasive evaluation of right ventricular function. Clin Chest Med 1987; 8: 65-80.

  16. Dubourg O, Jardin F, Quanadli S, Bourdarias JP: Évaluation de la fonction ventriculaire droite. Arch Mal Coeur Practique 1996; 39: 17-19.

  17. Klinger JR, Hill NS: Right ventricular dysfunction in chronic obstructive pulmonary disease. Evaluation and management. Chest 1991; 99: 715-723.

  18. Horn M, Witztum K, Neven C, Perkins G, Walsh B: Krypton-81m imaging of the right ventricle. J Nucl Med 1985; 26: 33-36.

  19. Ratner S, Huang P, Friedman M, Pierson R: Assessment of right ventricular anatomy and function by quantitative radionuclide ventriculography. J Am Coll Cardiol 1989; 13: 354-359.

  20. MacNee W: State of the art. Pathophysiology of cor pulmonale in chronic obstructive Pulmonary disease. Am J Respir Crit Care Med 1994; 150: 833-852.

  21. Guadalajara Boo JF: ¿Qué es insuficiencia cardíaca? Arch Inst Cardiol Méx 1998; 68(1): 7-11.

  22. Vizza CD, Lynch JP, Ochoa LL, Richardson G, Trulock EP: Right and left ventricular dysfunction in patients with severe pulmonary disease. Chest 1998; 113(3): 576-583.

  23. Weitzenblum E, Chaouat A: Right ventricular function in COPD. Can it be assessed reliably by the measurement of right ventricular ejection fraction? Chest 1998; 113(3): 567-569.

  24. García R: Evaluación de las funciones global y segmentaria del ventrículo izquierdo en el infarto agudo del miocardio. En: Cuarón A. “Cardiología Nuclear. Aplicaciones Clínicas”. 1a ed. México, D.F. Compañía Editorial Continental 1987: 403-409.

  25. Borer JS, Supino P, Wencker D, Aschermann M, Bacharach SL, Green MV: Assessment of coronary artery disease by radionuclide cineangiography. History, current applications, and new directions. Cardiol Clin 1994; 12(2): 333-357.

  26. Guadalajara JF, Meaney E: Remodelación ventricular, cardiorreparación y cardioprotección. Programa de actualización continua para cardiólogos (PAC Cardio-1, A-1). México, D.F. Sociedad Mexicana de Cardiología 1997: 8.

  27. Vallejo E, Guadalajara JF: Conceptos básicos sobre la génesis y significado de la hipertrofia miocárdica. Arch Inst Cardiol Méx 1996; 66(4): 360-369.

  28. Bazzino O, Navarro Estrada JL, Sosa Liprandi A, Presti C, Masoli O, Santopinto J, et al: Early treatment with low-dose enalapril after acute myocardial infarction: an equilibrium radionuclide angiographic study. J Nucl Cardiol 1997; 4: 133-139.

  29. White HD: Left ventricular function as an important endpoint of thrombolytic trials. J Interven Cardiol 1992; 5(2): 111-116.

  30. Toubol P, Andre-Fouët X, Leizorovicz A, Itti R, Lopez M, Sayegh Y, et al for the Groupe d’etude du pronostic de l’infarctus du myocarde (GREPI): Risk stratification after myocardial infarction. A reappraisal in the era of thrombolysis. Eur Heart J 1997; 18: 99-107.

  31. Rodríguez-Abrego G, Escobedo-de la Peña J, Unzueta: Factores predictores de sobrevida o de un segundo evento coronario en pacientes con un primer infarto agudo del miocardio. Arch Inst Cardiol Méx 1997; 67(1): 38-45.

  32. Gill VM, Ventosa A, Ferrer A, Morais J, Seabra-Gomes R: Left ventricular function after late thrombolysis with alteplase in myocardial infarction. Rev Port Cardiol 1996; 15(5): 413-420.

  33. Breekland A, Blanksma PK, Kengen RAM, Pieper EG, Crijns HJGM, Visser CA: Categorization of abnormal left ventricular function: Comparison between radionuclide angiographic and echocardiographic techniques in postinfarction patients. Am J Cardiol 1997; 79(1): 108-111.

  34. Alexánderson E: Diagnóstico de isquemia miocárdica por centelleografía con radionúclidos. Monografía del curso de Cardiopatía Isquémica Crónica. México, Instituto Nacional de Cardiología 1996: 47-48.

  35. Iftikhar I, Koutelou M, Mahmarian JJ, Verani MS: Simultaneous perfusion tomography and radionuclide angiography during dobutamine stress. J Nucl Med 1996; 37(8): 1306-1310.

  36. Manrique A, Faraggi M, Vera P, Vilain D, Lebtahi R, Cribier A, et al: 201TI and 99mTc-MIBI gated SPECT in patients with large perfusion defects and left ventricular dysfunction: comparison with equilibrium radionuclide angiography. J Nucl Med 1999; 40(5): 805-809.

  37. Kronenberg MW, Konstam MA, Edens TR, Howe DM, Dolan N, Udelson JE, et al: Factors influencing exercise performance in patients with left ventricular dysfunction, SOLVD Investigators. Studies of Left Ventricular Dysfunction. J Card Fail 1998; 4(3): 159-167.

  38. Bonow RO, Bacharach SL, Green MV, Kent KM, Rosing DR, Lipson LC, et al: Impaired left ventricular diastolic filling in patients with coronary artery disease: Assessment with radionuclide angiography. Circulation 1981; 64(2): 315-323.

  39. Borges-Neto S, Shaw LJ, Kesler KL, Hanson MW, Peterson ED, Morris El, et al: Prediction of severe coronary artery disease by combined rest and exercise radionuclide angiocardiography and tomographic perfusion imaging with technetium 99m-labeled sestamibi: A comparison with clinical and electrocardiographic data. J Nucl Cardiol 1997; 4(3): 189-194.

  40. García Moll M, Serra Grima R, Carrió I, Estorch M, Trilla E: Estudio comparativo de la isquemia miocárdica sintomática y silente mediante la ventriculografía isotópica de esfuerzo. Rev Lat Cardiol 1995; 16(4): 119-122.

  41. Iskandrian AS, Heo J: Radionuclide angiographic evaluation of left ventricular performance at rest and during exercise in patients with aortic regurgitation. Am Heart J 1986; 111(6): 1143-1149.

  42. Mena I, Sole C: Cuantificación de la regurgitación valvular. En: Cuarón A. “Cardiología Nuclear. Aplicaciones Clínicas”. 1ª ed. México, D.F. Compañía Editorial Continental 1987: 474.

  43. Braunwald E: Valvular heart disease. In: idem. “Heart disease. A textbook of cardiovascular medicine”. 5ª ed. Philadelphia. W.B. Saunders 1997: 1052-1053.

  44. Tarasoutchi F, Grinberg M, Parga J, Cardoso LF, izaki M, Pomerantzeff P, et al: Evolucao pós-operatoria da funcao ventricular esquerda na insuficiencia aórtica. Arq Bras Cardiol 1995; 65(2): 147-152.

  45. Shen WF, Roubin GS, Choong CYP, Hutton BF, Harris PJ, Fletcher PJ, et al: Evaluation of relationship between myocardial contractile state and left ventricular function in patients with aortic regurgitation. Circulation 1985; 71(1): 31-38.

  46. Bonow RO, Dodd JT, Maron BJ, O’Gara PT, White GG, Mclntosh CL, Clark RE, Epstein SE: Long-term serial changes in left ventricular function and reversal of ventricular dilatation after valve replacement for chronic aortic regurgitation. Circulation 1988; 78(5Pt1): 1108-1120.

  47. Starling MR: Responsiveness of the maximum time-varying elastance to alterations in left ventricular contractile state in man. Am Heart J 1989; 118(6): 1266-1276.

  48. Starling MR, Kirsh MM, Montgomery DG, Gross MD: Mechanisms for left ventricular systolic dysfunction in aortic regurgitation: importance for predicting the functional response to aortic valve replacement. J Am Coll Cardiol 1991; 17: 887-897.

  49. Guadalajara Boo JF: Remodelación ventricular, cardiorreparación y cardioprotección. México, Intersistemas 1997: 9-11, 28-30.

  50. Dymond DS, Wolf FG, Schmidt DH: Severe left ventricular dysfunction in critical aortic stenosis-reversal following aortic valve replacement. Postgrad Med J 1983; 59(698): 781-783.

  51. Harpole DH, Jones RH: Serial assessment of ventricular performance after valve replacement for aortic stenosis. J Thorac Cardiovasc Surg 1990; 99(4): 645-650.

  52. Ross J Jr: Afterload mismatch in aortic and mitral valve disease: implications for surgical therapy. J Am Coll Cardiol 1985; 5(4): 811-826.

  53. Natsuaki M, Itoh T, Tomita S, Naito K: Reversibility of cardiac dysfunction after valve replacement in elderly patients with severe aortic stenosis. Ann Thorac Surg 1998; 65(6): 1634-1638.

  54. Rediker DE, Boucher CA, Block PC, Akins CW, Buckley MJ, Fifer MA: Degree of reversibility of left ventricular systolic dysfunction after aortic valve replacement for isolated aortic valve stenosis. Am J Cardiol 1987; 60(1): 112-118.

  55. Santinga JT, Kirsh MM, Brady TJ, Thrall J, Pitt B: Radionuclide angiography in evaluation of left ventricular function following aortic valve replacement. Ann Thorac Surg 1981; 31(5): 409-413.

  56. Green GR, Miller DC: Continuing dilemmas concerning aortic valve replacement in patients with advanced left ventricular systolic dysfunction. J Heart Valve Dis 1997; 6(6): 562-579.

  57. Lavine SJ, Follansbee WP, Shreiner DP, Amidi M: Left ventricular diastolic filling in valvular aortic stenosis. Am J Cardiol 1986; 57(15): 1349-1355.

  58. Hwang MH, Hammermeister KE, Oprian C, Henderson W, Bousvaros G, Wong M, Miller DC, Folland E, Sethi G: Preoperative identification of Patients likely to have left ventricular dysfunction after aortic valve replacement. Participants in the Veterans Administration Cooperative Study on Valvular Heart Disease. Circulation 1989; 80(3, Pt 1): 165-176.

  59. Lund O, Flo C, Jensen FT, Emmertsen K, Nielsen TT, Rasmussen BS, Hansen OK, Pilegaard HK, Kristensen LH: Left ventricular systolic and diastolic function in aortic stenosis. Prognostic value after valve replacement and underlying mechanisms. Eur Heart J 1997; 18(12): 1977-1987.

  60. Braunwald E: Valvular heart disease. In: idem. “Heart disease. A textbook of cardiovascular medicine”. 5ª ed. Philadelphia. W.B. Saunders 1997: 1024-1025.

  61. Beller GA: Clinical Nuclear Cardiology. Philadelphia, W.B. Saunders Co 1995: 373-379.

  62. Gottdiener JS, Borer JS, Bacharach SL, Green MV, Epstein SE: Left ventricular function in mitral valve prolapse: assessment with radionuclide cineangiography. Am J Cardiol 1981; 47(1): 7-13.

  63. Boucher CA, Bingham JB, Osbakken MD, Okada RD, Strauss HW, Block PC, et al: Early changes in left ventricular size and function after correction of left ventricular overload. Am J Cardiol 1981; 47(5): 991-1004.

  64. Sánchez Torres G: Las miocardiopatías. En: Cuarón A. “Cardiología Nuclear. Aplicaciones Clínicas”. 1ª ed. México, D.F. Compañía Editorial Continental 1987: 447-458.

  65. Gilbert EM, Bristow MR: Idiopathic dilated cardiomyopathy. In: Schlant RC, Alexander RW. “Hurst’s the heart: arteries and veins”. 8a ed. New York. McGraw Hill 1994: 1609-1619.

  66. Chikamori T, Dickie S, Poloniecki JD, Myers MJ, Lavender JP, McKenna WJ: Prognostic significance of radionuclide assessed diastolic function in hvpertrophic cardiomyopathy. Am J Cardiol 1990; 65(7): 478-482.

  67. Maron BJ, Roberts WC: Hypertrophic cardiomyopathy. In: Schiant RC, Alexander RW. “Hurst’s the heart: arteries and veins”. 8a ed. New York. McGraw Hill 1994: 1621-1635.

  68. Bonow RO, Frederick TM, Bacharach SL, Green MV, Goose PW, Maron BJ, et al: Atrial systole and left ventricular filling in patients with hypertrophic cardiomyopathy: Effect of verapamil. Am J Cardiol 1983; 51: 1386-1391.

  69. Wynne J, Braunwald E: The cardiomyopathies and myocarditides. In: Braunwald E. “Heart disease. A textbook of cardiovascular medicine”. 5a ed. Philadelphia. W. B. Saunders Co 1997: 1422.

  70. Dilsizian V, Bonow RO, Epstein SE, Fananapazir L: Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1993; 22(3): 796-804.

  71. Rubier S, Diugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A: New type of cardiomyopathy associated with diabetic glomeruloesclerosis. Am J Cardiol 1972; 30: 595-602.

  72. Uusitupa MIJ, Mustonen JN, Airaksinen KEJ: Diabetic heart muscle disease. Ann Med 1990; 22: 377-386.

  73. Shapiro LM: Echocardiographic features of impaired ventricular function in diabetes mellitus. Br Heart J 1982; 47: 439-444.

  74. Danielsen R, Nordrehaug JE, Lien E, Vik-Mo H: Subclinical left ventricular abnormalities in young subjects with long-term type 1 diabetes mellitus detected by digitized M-Mode echocardiography. Am J Cardiol 1987; 60: 143-146.

  75. Vered Z, Battler A, Segal P, Liberman D, Yerushalmi Y, Berezin M, et al: Exercise-induced left ventricular dysfunction in young men with asymptomatic diabetes mellitus (Diabetic Cardiomyopathy). Am J Cardiol 1984; 54(6): 633-637.

  76. Zola B, Kahn JE, Juni JE, Vinik Al: Abnormal cardiac function in diabetic patients with autonomic neuropathy in the absence of ischemic heart disease. J Clin Endocrinol Metab 1986; 63: 208-214.

  77. Shuck JW, Walder J, Oetgen WJ, Thomas HM: Right ventricular visualization by thallium-201 myocardial scintigraphy in chronic obstructive pulmonary disease. South Med J 1985; 78(12): 1435-1439.

  78. Yamaoka S, Yonekura Y, Koide H, Ohi m, Kuno K: Noninvasive method to assess cor pulmonale in patients with chronic obstructive pulmonary disease. Chest 1987; 92: 10-17.

  79. Olvey SK, Reduto LA, Stevens PM, Deaton WJ, Miller RR. First pass radionuclide assessment of right and left ventricular ejection fraction in chronic pulmonary disease. Effect of oxygen upon exercise response. Chest 1980; 78(1): 4-9.

  80. Alexander J, Dainiak N, Berger HJ, Goldman L, Johnstone D, Reduto L, et al: Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiography. N Engf J Med 1979; 300(6): 278-283.

  81. Gottdiener JS, Mathisen DJ, Borer JS, Bonow RO, Myers CE, Barr LH, et al. Doxorubicin cardiotoxiticy: assessment of late left ventricular dysfunction by radionuclide cineangiography. Ann Intern Med 1981; 94(4 pt.1): 430-435.

  82. Massing JL, Caillot D, Mouhat T, Schlesser P, Solary E: Détection précoce de la toxicité cardiaque des anthracyclines. Intéret de I’étude isotopique. Arch Mal Coeur 1996; 89(1): 57-62.

  83. Sartori M, Andorno S, La Terra G, Pozzoli G, Rudoni M, Sacchetti GM, et al: Assessment of interferon cardiotoxicity with quantitative radionuclide angiocardiography. Eur J Clin Invest 1995; 25(1): 68-70.

  84. Oyamada H, Yamada Y, Nomura E, Nakanishi Y, Abe S, Horikoshi N, et al: Reliability of data obtained by radionuclide angiocardiography in follow-up studies with special reference to intra- and interobserver variations. Nucl Med Commun 1994; 15(9): 690-696.




2020     |     www.medigraphic.com